Screening compound: InChI=1S/C18H17FN4O3S2/c19-13-4-1-2-6-15(13)22-8-10-23(11-9-22)17(24)12-28(25,26)16-7-3-5-14-18(16)21-27-20-14/h1-7H,8-12H2

Screening compound: InChI=1S/C18H17FN4O3S2/c19-13-4-1-2-6-15(13)22-8-10-23(11-9-22)17(24)12-28(25,26)16-7-3-5-14-18(16)21-27-20-14/h1-7H,8-12H2
Screening compound: InChI=1S/C18H17FN4O3S2/c19-13-4-1-2-6-15(13)22-8-10-23(11-9-22)17(24)12-28(25,26)16-7-3-5-14-18(16)21-27-20-14/h1-7H,8-12H2 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C18H17FN4O3S2/c19-13-4-1-2-6-15(13)22-8-10-23(11-9-22)17(24)12-28(25,26)16-7-3-5-14-18(16)21-27-20-14/h1-7H,8-12H2

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G845-0107

Molecular Formula

C18H17FN4O3S2 (C18 H17 FN4 O3 S2)

Compound Name

2-(2,1,3-benzothiadiazole-4-sulfonyl)-1-[4-(2-fluorophenyl)piperazin-1-yl]ethan-1-one

IUPAC name

2-(213-benzothiadiazole-4-sulfonyl)-1-[4-(2-fluorophenyl)piperazin-1-yl]ethan-1-one

SMILES

O=C(CS(c1cccc2nsnc12)(=O)=O)N(CC1)CCN1c(cccc1)c1F

InChI

InChI=1S/C18H17FN4O3S2/c19-13-4-1-2-6-15(13)22-8-10-23(11-9-22)17(24)12-28(25,26)16-7-3-5-14-18(16)21-27-20-14/h1-7H,8-12H2

InChI Key

DHVOIXFNQQJBTM-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15039834

InChI=1S/C18H17FN4O3S2/c19-13-4-1-2-6-15(13)22-8-10-23(11-9-22)17(24)12-28(25,26)16-7-3-5-14-18(16)21-27-20-14/h1-7H,8-12H2 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein-Protein Interaction Library (218420 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Chemokine Receptor-Targeted Library (18382 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
Therapeutical areas:
  • Immune system

References: we are preparing a list of scientific research reports with InChI=1S/C18H17FN4O3S2/c19-13-4-1-2-6-15(13)22-8-10-23(11-9-22)17(24)12-28(25,26)16-7-3-5-14-18(16)21-27-20-14/h1-7H,8-12H2 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C18H17FN4O3S2/c19-13-4-1-2-6-15(13)22-8-10-23(11-9-22)17(24)12-28(25,26)16-7-3-5-14-18(16)21-27-20-14/h1-7H,8-12H2?
Check Price and Availability of InChI=1S/C18H17FN4O3S2/c19-13-4-1-2-6-15(13)22-8-10-23(11-9-22)17(24)12-28(25,26)16-7-3-5-14-18(16)21-27-20-14/h1-7H,8-12H2, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C18H17FN4O3S2/c19-13-4-1-2-6-15(13)22-8-10-23(11-9-22)17(24)12-28(25,26)16-7-3-5-14-18(16)21-27-20-14/h1-7H,8-12H2 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C18H17FN4O3S2/c19-13-4-1-2-6-15(13)22-8-10-23(11-9-22)17(24)12-28(25,26)16-7-3-5-14-18(16)21-27-20-14/h1-7H,8-12H2
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C18H17FN4O3S2/c19-13-4-1-2-6-15(13)22-8-10-23(11-9-22)17(24)12-28(25,26)16-7-3-5-14-18(16)21-27-20-14/h1-7H,8-12H2
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C18H17FN4O3S2/c19-13-4-1-2-6-15(13)22-8-10-23(11-9-22)17(24)12-28(25,26)16-7-3-5-14-18(16)21-27-20-14/h1-7H,8-12H2 available by request